Advanced search×

Monoclonal and biclonal gammopathy in two patients infected with Bartonella henselae.

Ann Hematol 82(7):455-7 (2003) PMID 12764550

Two immunocompetent patients with cat-scratch disease due to infection with Bartonella henselae developed monoclonal and biclonal gammopathy. Neither patient had evidence of any other known cause of plasma cell dyscrasia, and antibiotic eradication of Bartonella henselae infection resulted in the prompt disappearance of the gammopathy. Hence, cat-scratch disease should be added to the list of possible underlying disorders in individuals presenting with monoclonal and biclonal gammopathy.

DOI: 10.1007/s00277-003-0675-4
Version: za2963e q8zaf q8zb1 q8zcb q8zdd q8zeb q8zf9 q8zg4

Similar articles you may find interesting…

  1. B-Cell Depletion With Rituximab in Patients With Primary Biliary Cirrhosis Refractory to Ursodeoxycholic Acid.

    Am J Gastroenterol (2013) PMID 23649186

    Selective B-cell depletion with rituximab was safe and associated with a significant decrease in autoantibody production, but had limited biochemical efficacy in PBC patients with an incomplete response to UDCA.Am J Gastroenterol advance online publication, 7 May 2013; doi:10.1038/ajg.2013.51....
  2. Laparoscopy and peritoneal cytology: important prognostic tools to guide treatment selection in gastric adenocarcinoma.

    ANZ J Surg (2013) PMID 23647832

    Laparoscopy and peritoneal cytology add incremental value to modern imaging in the staging of gastric adenocarcinomas by detecting occult metastatic disease. Their utility needs to be optimized to allow better treatment selection for gastric cancer patients. © 2013 The Authors. ANZ...
  3. Predictors of Mortality and Outcomes of Therapy in Low Flow Severe Aortic Stenosis: A PARTNER Trial Analysis.

    Circulation (2013) PMID 23661722

    Low flow is common in severe AS and independently predicts mortality. Survival is improved with TAVR as compared to MM and similar with TAVR and SAVR. A measure of flow (SVI) should be included in the evaluation and therapeutic decision making of patients with severe AS. CLINICAL TRIAL REGISTRATION...